Wedbush raised the firm’s price target on SpringWorks Therapeutics (SWTX) to $81 from $77 and keeps an Outperform rating on the shares ...

We recently compiled a list of the 10 Important AI News and Ratings for Today. In this article, we are going to take a look at where Advanced Micro Devices, Inc. (NASDAQ:AMD) stands against the ...

Furthermore, Wedbush analyst, Dan Ives called it a buying opportunity for American tech stocks. He wrote in a post on X: “DeepSeek is a competitive LLM model for consumer use cases…launching broader ...

NEW YORK, January 28, 2025--(BUSINESS WIRE)--Wedbush Securities, a global independent financial services firm, announces the promotion of three members within its Investment Banking & Capital ...

On January 27, Wedbush lowered Intel’s (NASDAQ:INTC) price target from $25 to $20 while maintaining a Neutral rating ahead of the January 30 earnings report. The firm adjusted its long-term ...

Wedbush analysts view the technology selloff this morning as a “golden buying opportunity.” No U.S. global 2000 company is going to use a Chinese start-up DeepSeek to launch their artificial ...

Based on its Washington D.C. interactions with officials, Wedbush expects the Trump administration to propel Tesla forward, especially with self-driving cars and AI technology. According to many ...

Wedbush Securities hiked its base case price target on Tesla (NASDAQ:TSLA) to $550 from $515 on its view that the golden age of autonomous, FSD, and Optimus has arrived. The firm has growing ...